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Abstract: The periplasmic aldehyde oxidoreductase PaoABC from Escherichia coli is a 
molybdenum enzyme involved in detoxification of aldehydes in the cell. It is an example 
of an αβγ heterotrimeric enzyme of the xanthine oxidase family of enzymes which does not 
dimerize via its molybdenum cofactor binding domain. In order to structurally characterize 
PaoABC, X-ray crystallography and small angle X-ray scattering (SAXS) have been 
carried out. The protein crystallizes in the presence of 20% (w/v) polyethylene glycol 3350 
using the hanging-drop vapour diffusion method. Although crystals were initially twinned, 
several experiments were done to overcome twinning and lowering the crystallization 
temperature (293 K to 277 K) was the solution to the problem. The non-twinned crystals 
used to solve the structure diffract X-rays to beyond 1.80 Å and belong to the C2 space 
group, with cell parameters a = 109.42 Å, b = 78.08 Å, c = 151.77 Å, β  = 99.77°, and one 
molecule in the asymmetric unit. A molecular replacement solution was found for each 
subunit separately, using several proteins as search models. SAXS data of PaoABC were 
also collected showing that, in solution, the protein is also an αβγ heterotrimer. 
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1. Introduction 
Molybdenum is a transition metal that is incorporated, as a biologically active cofactor 
(molybdenum cofactor, Moco), in a class of widely distributed proteins collectively known as 
molybdoenzymes [1]. Moco is associated with a wide range of redox enzymes and is found in most 
organisms from bacteria to humans. The metal in Moco is coordinated to a pterin derivative called 
molybdopterin to form the molybdenum containing molybdopterin (Mo-MPT) cofactor [2]. A wide 
variety of transformations are catalyzed by these enzymes at carbon, sulfur and nitrogen atoms, which 
include the transfer of an oxo group or two electrons to or from the substrate. Depending on the ligands 
of the molybdenum center in Moco, molybdoenzymes are classified into three families: (i) the xanthine 
oxidase (XO) family, characterized by a cyanolyzable equatorial sulfur ligand coordinated to the 
molybdenum atom; (ii) the sulfite oxidase family, with two oxo ligands at the molybdenum center; and 
(iii) the dimethylsulfoxide (DMSO) reductase family, where one molybdenum atom is coordinated by 
two dithiolene groups [1,3,4]. While in eukaryotes Moco is present solely in its Mo-MPT form, in 
bacteria additional variability of the Moco is achieved by attachment of a second nucleotide, GMP or 
CMP to the phosphate group of MPT [5–7]. 
The XO family of molybdoenzymes comprises a number of different enzymes in prokaryotes and 
eukaryotes, all transferring oxygen derived from water to their substrate. Most enzymes of the XO 
family are well characterized as purine and/or aldehyde oxidizing enzymes with broad substrate 
specificities, but also several more specific enzymes like carbon monoxide dehydrogenase and nicotine 
dehydrogenase have been described [8,9]. Well-characterized enzymes with aldehyde-oxidizing 
activity are Desulfovibrio gigas aldehyde oxidoreductase and mammalian aldehyde oxidases [10]. 
Mammalian aldehyde oxidases are expressed at high levels in the liver and in the lung and have  
been implicated in the detoxification of environmental pollutants and xenobiotics [11]. Bacterial 
aldehyde oxidases and aldehyde dehydrogenases were identified in different bacteria, including 
Methylococcus sp., Pseudomonas sp., Streptomyces moderatus [12], Amycolatopsis methanolica [13] 
and Pseudomonas testosteroni [14]. In addition, xanthine dehydrogenases (XDH) capable of oxidizing 
various purine and aldehyde substrates were characterized in bacteria like Rhodobacter capsulatus [15], 
Pseudomonas putida 86 [16,17], and Veillonella atypica [18,19]. With the exception of R. capsulatus 
and Pseudomonas aeruginosa XDH [20,21] which binds Mo-MPT, all bacterial XDHs characterized to 
date bind the molybdopterin cytosine dinucleotide (MCD) form of Moco. In these XDHs, molecular 
masses range from 140 to 300 kDa and different subunit structures were observed, like α2 in 
Steptomyces cyanogenus [22], αβγ in V. atypica [19], α3 in P. putida [23], α2β2 in R. capsulatus [15], 
α2β2 in Comamonas acidovorans [24,25], and α4β4 in P. putida 86 [17]. However, in general, enzymes 
of the XO family possess the same overall architecture [26], with two distinct [2Fe–2S] clusters bound 
to the N-terminal domain or subunit, a flavin adenine dinucleotide (FAD) bound to a central domain or 
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subunit (with the exception of D. gigas aldehyde oxidoreductase in which the FAD binding domain is 
absent [27]) and the Moco-binding domain at the C-terminus. 
Among the members of the xanthine oxidase family in E. coli are the xanthine dehydrogenase 
XdhABC, the periplasmic aldehyde oxidoreductase PaoABC, and the so far uncharacterized xanthine 
dehydrogenase homologue XdhD [28]. The paoABCD operon encodes for a molybdenum-containing 
iron–sulfur flavoprotein that is located in the periplasm [29]. The 135 kDa enzyme comprises a 
noncovalent (αβγ) heterotrimer with a large (78.1 kDa) molybdenum cofactor (Moco)-containing  
PaoC subunit, a medium (33.9 kDa) FAD-containing PaoB subunit, and a small (21.0 kDa)  
2× [2Fe2S]-containing PaoA subunit, which also contains the Tat-leader peptide for the localization to 
the periplasm. PaoD is not a subunit of the mature enzyme, and the protein is expected to be involved 
in Moco modification and insertion into PaoABC. Analysis of the form of Moco present in PaoABC 
revealed the presence of the MCD cofactor [29]. Kinetic characterization of the enzyme showed that 
PaoABC converts a broad spectrum of aldehydes, with a preference for aromatic aldehydes. The 
terminal electron acceptor of the enzyme has not been identified to date, however, NAD+ is not used as 
terminal electron acceptor and the reactivity with molecular oxygen is very slow. Complete growth 
inhibition of E. coli cells devoid of genes from the paoABC operon was observed by the addition of 
cinnamaldehyde to a low-pH medium. This finding showed that PaoABC might have a role in the 
detoxification of aromatic aldehydes for E. coli under certain growth conditions [29]. 
Here, we describe the crystallization experiments and preliminary X-ray diffraction data of the 
enzyme purified after homologous expression in E. coli. Additional SAXS experiments confirmed the 
αβγ heterotrimeric structure of the enzyme. 
2. Results and Discussion 
2.1. Crystallization and Data Processing 
To crystallize the periplasmic aldehyde oxidoreductase (PaoABC) from E. coli several screens were 
tested. The protein crystallizes with 0.2 M ammonium iodide and 20% (w/v) polyethylene glycol 3350 
(Figure 1). Two crystallization temperatures were used, 277 and 293 K (crystals_A and crystals_B, 
respectively), and several plate-like crystals appeared after four or two days, respectively. The datasets 
collected for both types of crystals diffracted to high resolution (1.67 and 1.8 Å, respectively) and 
presented similar processing statistics (Table 1). The crystals belong to the centred monoclinic space 
group C2 and the Matthews coefficient calculations suggest the presence of one heterotrimer (αβγ) per 
asymmetric unit, (Matthews coefficient of 2.7 Å3/Da) with a solvent content of 48%. 
Analysis using TRUNCATE [30] and XTRIAGE [31] showed normalized structure amplitudes <E> 
of 0.903 and 0.936, for the crystals grown at 277 K and 293K, respectively. Since the expected value 
for a non-twinned dataset is 0.886 and for a perfectly twinned data set is 0.94, the obtained values 
suggest the presence of twinning for the crystals prepared at highest temperature. As several problems 
may arise during phasing and refinement [32] for twinned data, the non-twinned dataset was used to 
solve the PaoABC structure. 
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Figure 1. Crystals of PaoABC grow in 0.2 M ammonium iodide and 22% (w/v) 
polyethylene glycol 3350. 
 
Table 1. Data-collection and processing statistics for two types of PaoABC crystals. 
Values in parentheses are for the highest resolution shell. 
 Twinned crystals (A) (293 K) Non-twinned crystals (B) (277 K) 
Data collection parameters   
X-ray Source ID14-1 beam line (ESRF, Grenoble) X06DA—PXIII beam line (SLS, Villigen) 
Detector ADSC Q210 CCD PILATUS 2 M 
Wavelength (Å) 0.934 0.976 
Processing statistics   
Unit-cell parameters (Å, °) 
a = 109.50 a = 109.42 
b = 78.16 b = 78.08 
c = 151.84 c = 151.77 
β = 100.15 β = 99.77 
Space group C2 C2 
Molecules per AU 1 1 
Matthews coefficient (Å3/Da) 2.70 2.73 
Mosaicity (°) 0.79 0.64 
Resolution range (Å) 30.88–1.67 (1.76–1.67) 41.23–1.80 (1.88–1.80) 
<I/σI> 12.8 (5.9) 9.91 (2.41) 
Rmerge (%) * 6.1 (16.8) 7.7 (46.2) 
Rpim (%) + 3.9 (11.1) 5.2 (30.9) 
Multiplicity 3.0 (3.0) 2.9 (2.8) 
No. of observed reflections 379108 (50315) 324367 (40070) 
No. of unique reflections 124566 (16919) 108448 (9450) 
Completeness (%) 85.2 (79.7) 92.3 (80.7) 
* 𝑅𝑚𝑒𝑟𝑔𝑒 =  ∑ ∑ |𝐼𝑖𝑖ℎ𝑘𝑙 (ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/∑ ∑ 𝐼𝑖𝑖ℎ𝑘𝑙 (ℎ𝑘𝑙); 
+ 𝑅𝑝𝑖𝑚 =  ∑ �
1
𝑁−1
� 1/2 ∑ |𝐼𝑖𝑖ℎ𝑘𝑙 (ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|/∑ ∑ 𝐼𝑖𝑖ℎ𝑘𝑙 (ℎ𝑘𝑙). 
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2.2. Structure Determination 
To solve the structure of PaoABC, sequence alignment searches were performed separately for each 
subunit in order to find the best homologous models that could lead to good initial phases obtained by 
molecular replacement. For subunit A, 4-hydroxybenzoyl-CoA reductase from Thauera aromatica 
(TaHBRC, PDB code 1rm6) [33]), quinoline 2-oxidoreductase from Pseudomonas Putida 86 (PpQoR, 
PDB code 1t3q) [34] and carbon monoxide dehydrogenase from Hydrogenophaga pseudoflava 
(HpCODH, PDB code 1ffu) were used; for subunit B, TaHBCR, HpCODH (PDB code 1ffu and 1ffv) 
were used; and for subunit C, TaHBCR, Bos taurus xanthine oxidase complexed with xanthine (BtXO, 
PDB code 3eub) and reduced BtXO in complex with arsenite (PDB code 3sr6) [35] were used as models. 
In order to optimize the structure solution, Chainsaw [36] was used, pruning non-conserved 
residues prior to PHASER [37], from the CCP4 package. Three steps of molecular replacement were 
necessary to solve the structure of the protein, finding the position of each subunit separately. In the 
final solution, positive electron density was found at the expected position of the cofactors MCD,  
2× [2Fe-2S] clusters and FAD, that had been excluded from the search models, thus confirming the 
correctness of the solution. Anomalous maps have also been calculated in order to help positioning 
heavy atoms in the electron density. Even though molybdenum and iron have low anomalous 
contribution at 0.976 Å wavelength (distant from the adsorption peak at 0.62 Å and 1.74 Å, 
respectively), strong anomalous peaks could be found for the Mo atom at the enzyme active site and 
for iron at the electron transfer centres. 
The data-collection and processing statistics are presented in Table 1 and the crystal structure is 
currently under refinement. 
2.3. Quaternary Structure Analysis of PaoABC 
While all the enzymes of the XO family that have so far been analysed by crystallography  
exhibit dimeric structures (homodimers or dimers of heterotrimers (heterodimers) [38]), biochemical 
analysis suggested that PaoABC does not dimerize via its Moco-binding domain and remains an αβγ 
heterotrimer in solution. Although only one molecule is found in the asymmetric unit, we analysed  
the crystal packing from the position of the crystallographic dyads. This was first done by visual 
inspection and no tight packing could be identified (Figure 2). In addition, we used the PISA server 
(Protein Interfaces, Surfaces and Assemblies) [39] that predicted the ABC arrangement based on 
chemical thermodynamic calculations. The solvation free energy gain (ΔGint) of −163.1 kcal/mol  
and the free energy of assembly dissociation (ΔGdiss) of 22.8 kcal/mol shows that PaoABC is 
thermodynamically stable as αβγ heterotrimer [39]. 
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Figure 2. Crystal packing of PaoABC. Cartoon representation of several asymmetric units 
of PaoABC untwinned crystals with subunit A in orange, B in green and C in blue when 
viewed along the c axis and rotated 90°. Picture prepared using PyMOL 1.5.0.3 [40]. 
 
2.4. Small-Angle X-ray Scattering of PaoABC 
SAXS experiments have also been performed for PaoABC in order to further explore the structure 
and oligomerization state of the protein in solution. Monodisperse concentrated solutions of PaoABC 
were measured and the processed scattering profile of PaoABC are presented in Figure 3. The 
structural parameters including the radius of gyration (Rg), the maximum particle dimension (Dmax) and 
the excluded (Porod) volume of the hydrated particle computed from the experimental data are 
summarized in Table 2. The distance distribution function, P(r), obtained from the experimental data 
suggests that the protein is well folded and has a globular structure (Figure 3). The molecular mass 
(MM) of the solute estimated from the forward scattering I(0) and also from the Porod volume  
(Table 2) are both close to that of the monomeric PaoABC (136 kDa) indicating that the protein is a 
heterotrimer in solution. 
The overall shape of PaoABC was calculated ab initio from its scattering profile using programs 
DAMMIN [41] and DAMMIF [42]. The most typical model out of 20 reconstructions as analysed by 
DAMAVER [43] is overlapped in Figure 4 with the crystallographic structure of the monomer of 
TaHBRC (PDB code 1rm6, [33]). The reconstructed shape matches well with the overall appearance 
of the crystal structure. The experimental SAXS data were also fitted by the scattering profile 
calculated from the crystal structure of the monomeric 4-hydroxybenzoyl-Coa reductase using 
CRYSOL [44]. The crystal structure yielded Rg = 31 Å, somewhat smaller than the experimental value. 
The fit showed a discrepancy of χ = 1.3 (Figure 3) confirming that the overall shape of PaoABC is 
reasonably close to that of monomeric 1rm6, but also showing systematic deviations and indicating 
that PaoABC may be somewhat more extended in solution. In contrast, the scattering computed from 
the crystallographic dimer of 1rm6 provides an extremely poor fit to the SAXS data (Figure 3) with 
discrepancy χ = 3.1 and also the radius of gyration of the dimer (Rg = 43 Å) does not match the 
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experimental data. Taken together, the SAXS data indicate that PaoABC is a heterotrimeric protein in 
solution with the overall structure similar but somewhat more extended than that of the monomeric  
4-hydroxybenzoyl-Coa reductase. 
Figure 3. SAXS data from PaoABC in solution. The experimental data (1) are displayed as 
black dots with grey error bars, and the scattering computed from the models is shown as 
smooth lines: (2) is the scattering from the ab initio shape, (3) and (4) are scattering 
computed from the monomer and dimer of 1rm6, respectively. Logarithm of the scattering 
intensity is displayed as a function of the momentum transfer s. Insert, the characteristic 
function of PaoABC computed from the scattering data. 
 
Table 2. SAXS Data collection and derived parameters for PaoABC. Abbreviations:  
Mr: molecular mass; Rg: radius of gyration; Dmax: maximal particle dimension; Vp: Porod 
volume; Vex: Particle excluded volume. a Momentum transfer |q| = 4πsin(θ)/λ. b Values 
reported for the data merged data set (0.3 & 10 mg/mL). 
Data collection parameters  
Instrument 
EMBL X33 beam line  
(DORIS-III, DESY, Hamburg) 
Beam geometry 2.0 × 0.6 mm2 
Wavelength (Å) 1.5 
q range (Å−1) a 0.01–0.5 
Exposure time (s) 8 × 15 
Concentration range (mg/mL) 0.3–20 
Temperature (K) 293 
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Table 2. Cont. 
Data collection parameters  
Structural parameters b  
I(0) (relative) [from p(r)] 120 ± 1 
Rg (Å) [from p(r)] 36 ± 1 
I(0) (cm−1) (from Guinier) 120 ± 1 
Rg (Å) (from Guinier) 35 ± 1 
Dmax (Å) 120 ± 10 
Porod volume estimate (Å3) 200,000 ± 10,000 
Excluded volume estimate (Å3) 240,000 ± 10,000 
Molecular-mass determination  
I(0) (cm−1) BSA (66,000 Da) 60 ± 1 
Molecular mass Mr (Da) [from I(0)] 130,000 ± 15,000 
Molecular mass Mr (Da)  
[from Porod volume (Vp/1.6)] 
125,000 ± 10,000 
Molecular mass Mr (Da)  
[from excluded volume (Vex/2)] 
120,000 ± 10,000 
Calculated monomeric Mr from sequence 136,000 
Software employed  
Primary data reduction Automated SAXS pipeline 
Data processing PRIMUS 
Ab initio analysis DAMMIN, DAMMIF 
Validation and averaging SUPCOMB, DAMAVER 
Computation of model intensities CRYSOL 
3D graphics representations VMD 
Figure 4. Superposition of the ab initio envelope of PaoABC (transparent beads, the most 
typical reconstruction from twenty DAMMIF runs) with the ribbon representation of the 
crystallographic monomer of 1rm6. Right panel is rotated 90 degrees counterclockwise 
along the vertical axis. 
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3. Experimental Section 
3.1. Crystallization 
PaoABC was expressed and purified using the procedure described previously [29]. The enzyme 
was concentrated to 20 mg/mL in 50 mM Tris-HCl pH 7.5, 250 mM NaCl, 1 mM EDTA with a 
Vivaspin 20 ultrafiltration device (Sartorius Stedim Biotech S.A., Goettingen, Germany). The final 
concentration was determined from the absorbance at 445 nm, using an extinction coefficient of 
23,686 M−1·cm−1 for the native enzyme. The extinction coefficient was determined on the basis of 
FAD content after trichloroacetic acid precipitation [45]. 
The first crystallization screening experiments were performed at 293 K by hanging-drop vapour 
diffusion with 1 µL of protein to 1 µL of precipitant solution on 24 well crystallization plates 
(Molecular Dimensions, Suffolk, UK) using several commercial screenings, namely PEG/Ion HT 
(Hampton Research, Aliso Viejo, CA, USA), JBScreen Classic 1-10 (Jena Bioscience, Jena, Germany), 
and an 80 condition in-house screen (based on the screen of Jancarik et al. [46]). 
PaoABC crystallized only in one condition of the commercial screen PEG/Ion HT that contains  
0.2 M ammonium iodide and 20% (w/v) polyethylene glycol (PEG) 3350. Red, plate shape crystals 
appeared within two days. However, the first datasets (collected and processed) revealed that the 
crystals measured were twinned, with a twinning fraction of 50% [31]. To overcome this, several 
concentrations of ammonium iodide (between 0.1 M and 0.25 M), percentage of PEG 3350 (between 
10% and 30%), proportions of drop and additives (Additive 1 and 2, Hampton Research) were tested 
but without success. When the crystallization temperature was changed from 293 K to 277 K, the 
crystals took four days to appear reaching maximum dimensions of 0.1 × 0.1 × 0.02 mm3 in the same 
crystallization condition. These crystals were untwinned and were used to solve the structure. 
3.2. Data Collection and Processing 
The crystals were flash-cooled directly in liquid nitrogen using as cryoprotectant a solution of  
30% (v/v) glycerol, 0.2 M ammonium iodide and 22% (w/v) polyethylene glycol 3350 and maintained 
at 100 K under a stream of nitrogen gas during data collection. 
For the crystals prepared at 293 K, several datasets were collected at beamline ID14-1 and BM14 at 
the European Synchrotron Radiation Facility (ESRF, Grenoble, France) (twinned crystals—A). For the 
crystals that were prepared at 277 K, the data was collected at X06DA—PXIII at Swiss Light Source 
(SLS, Villigen, Switzerland) (non-twinned crystals—B). Crystals A and B diffracted up to 1.67 Å at a 
wavelength of 0.934 Å and 1.80 Å at a wavelength of 0.976 Å, respectively. Both crystal types belong 
to C2 space group with similar unit-cell parameters: a = 109.50, b = 78.16, c = 151.84 Å, β = 100.15° 
for crystals A and a = 109.42, b = 78.08, c = 151.77 Å, β = 99.77° for crystals B. Matthews coefficient 
was calculated (ca 2.7 Å3/Da) [47] suggesting the presence of one heterotrimer per asymmetric unit, 
with a solvent content of 48%. 
Data were processed with iMOSFLM v.1.0.7 [48] and SCALA [49] from the CCP4 program 
package v. 6.3.0 (Collaborative Computational Project, Number 4, 1994) [50]. 
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3.3. Structure Solution 
Structure determination was performed with PHASER [37] using as molecular models the  
4-hydroxybenzoyl-CoA reductase from Thauera aromática (TaHBRC, PDB code 1rm6) [33], 
Quinoline 2-Oxidoreductase from Pseudomonas Putida 86 (PpQoR, PDB code 1t3q) [34] and Carbon 
monoxide dehydrogenase from Hydrogenophaga pseudoflava (HpCODH, PDB code 1ffu) [51] for 
subunit A; TaHBCR, hpCODH (PDB code 1ffu and 1ffv) for subunit B and, TaHBCR,  
Desulfo-Xanthine Oxidase with xanthine (PDB code 3eub) [52] and reduced Xanthine Oxidase in 
complex with arsenite (PDB code 3sr6) [35] from Bos taurus for subunit C. Density modification 
protocols [53] were applied giving initial phases with ca 0.7 mean figure of merit. 
3.4. SAXS Assays 
SAXS data were collected at the EMBL beamline X33 at DESY in Hamburg [54]. The 
measurements were performed at 293 K and different concentrations ranging from 0.3 to 30 mg/mL 
were used. Data were recorded using a Pilatus 1 M pixel detector at a sample-detector distance of  
2.7 m and a wavelength of 1.5 Å, covering the range of momentum transfer 0.01 < q < 0.6 Å−1 (here,  
q = 4π sinθ/λ, where 2θ is the scattering angle). Sample solutions were circulated in a thermostated 
cuvette, positioned within a vacuum chamber. Eight frames of 15 s each were collected, normalized to 
the transmitted intensity, and subsequently averaged using AUTOSUB [55]. The data were processed 
with the ATSAS package [56] using standard procedures, corrected for buffer contribution, and 
extrapolated to infinite dilution using the program PRIMUS [57]. The forward scattering I(0) and the 
radii of gyration Rg were evaluated using the Guinier approximation assuming that at very small angles 
(q < 1.3/Rg) the intensity is represented as I(s) = I(0) exp(−( qRg)2/3). These parameters were also 
computed from the entire scattering pattern using the indirect transform package GNOM [58] that also 
provides the maximum dimension of the particle Dmax and the distance distribution function P(r). The 
excluded volume of the hydrated particle (the Porod volume, Vp) was computed using the  
Porod invariant [59]. The program CRYSOL was used to compute the scattering from the known  
high-resolution models of TaHBRC (PDB code 1rm6) [44]. The ab initio modeling programs 
DAMMIN [41] and DAMMIF [42] were employed for low-resolution shape generation, and 20 
models were calculated in the slow mode, using standard settings. The program DAMAVER [43] was  
utilized to superimpose individual structures, and to determine the averaged and the most  
probable reconstruction. The ab initio model was superimposed with the high-resolution structure  
of 4-hydroxybenzoyl-Coa reductase using SUPCOMB [60]. 
4. Conclusions 
In this work we reported the crystallization of a periplasmic aldehyde oxidoreductase from E. coli 
using polyethylene glycol as precipitating agent. The first diffraction experiments revealed the 
presence of twinning in the crystals that posed difficulties in solving the structure. We could however 
overcome the problem by changing the crystallization temperature, which was decreased from 293 to  
277 K. Using non-twinned crystals (grown at 277 K) complete data could be collected that allowed the 
solution of the PaoABC crystal structure by molecular replacement using the structures of related 
Int. J. Mol. Sci. 2014, 15 2233 
 
 
molybdenum proteins as search models. The initial calculated maps showed good electron density for 
the Moco, the two [2Fe-2S] and FAD. The refinement of the crystallographic model of PaoABC is 
currently under way and will provide valuable information regarding the residues involved in the 
electron pathway between the existing centres as well as details of the active site. 
SAXS data have also been collected and, combined with the X-ray crystallographic information, 
allowed to characterize PaoABC, the first example of an enzyme of the XO family to be structurally 
analysed which forms a heterotrimer in solution and does not dimerize via its Moco-binding domain. 
Studies of PaoABC in solution and in the crystalline state will be pursued towards the 
understanding of its enzymatic mechanism as well as for the clarification of the interaction of this 
enzyme with its cognate chaperone, the dimeric protein PaoD. 
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